Agios Pharmaceuticals | Capital Social Ordinario



Ordinary Share Capital Cambio Fecha
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Arrowhead Research USD 138.14M 137.91M 2025-06
Astellas Pharma JPY 1.79B 101.21B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Bayer EUR 982.42M 1.53B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Daiichi Sankyo JPY 1.85B 48.15B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Agios Pharmaceuticals Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.